Skip to content

Randomized controlled trials of different treatment options for fetal growth restriction

Randomized controlled trials of different treatment options for fetal growth restriction

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093775
Enrollment
Unknown
Registered
2024-12-11
Start date
2025-01-01
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fetal growth restriction

Interventions

Observing and expecting treatment:Regularly monitor fetal heart rate and evaluate fetal growth through ultrasound. If the condition of the fetus deteriorates, consider timely intervention.
Nutrition support treatment:Provide a high calorie, high protein diet, and provide nutritional support through intravenous infusion if necessary
Anticoagulant therapy:According to the physician's recommendation, use low molecular weight heparin (such as enoxaparin) for anticoagulant therapy. Monitor bleeding risk and hematological indicators t
Nutritional support combined with anticoagulant therapy:Simultaneously implement nutritional support and anticoagulant therapy, and comprehensively evaluate the effectiveness

Sponsors

West China Second University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Pregnant women between 24 and 34 weeks of gestation who meet the diagnostic criteria for FGR (bilateral abdominal circumference or body weight less than the 10th percentile); 2. No serious complications (such as cardiovascular disease, kidney disease, etc.); 3. Have a good psychological state and be able to cooperate with research.

Exclusion criteria

Exclusion criteria: 1. The fetus has severe deformities or congenital diseases; 2. There are serious pregnancy complications (such as placental abruption, placenta previa, etc.); 3. Pregnant women who cannot be followed up (such as going abroad, transferring hospitals, etc.).

Design outcomes

Primary

MeasureTime frame
Growth and development status of fetus;

Countries

China

Contacts

Public ContactLi Xin

West China Second University Hospital

xinlicwcch@163.com+86 187 1637 0526

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026